Globalpharma spearheads drive to shape next generation of science leaders in UAE

Globalpharma has been offering internship training programs since 2002 in a variety of disciplines such as Pharmaceutical Manufacturing, Engineering, Quality Control, and Quality Assurance, with more than 50 students going through the program every year.

Commenting on the program, Jamil Akhtar, General Manager of Globalpharma said, "Today's students are tomorrow's leaders in the sciences. At Globalpharma, we understand the critical importance of preparing students for careers in the biomedical and pharmaceutical industry, and have taken it upon ourselves to ensure that promising young talents in the country have every opportunity to learn and flourish."

"Through our various training programs in Production, Instrumentation, Microbiology, and Analytical Sciences, we offer a unique opportunity for students in the UAE to fine-tune their research skills which adds invaluably to their academic curriculum. The programs give students an opportunity to work on challenging projects, learn about the pharmaceutical industry and apply their skills in a world-class manufacturing organization," Akhtar added.

"We view the internship program as an excellent opportunity for students to learn about us and for us to learn about them. The overriding objective here is to give these students a practical exposure to the everyday workings of the pharmaceutical industry and help them develop and apply their skills and knowledge to prepare for a successful career in pharmaceutical sciences," Akhtar said.

Globalpharma is Dubai's first pharmaceutical manufacturing company, manufacturing and marketing pharmaceutical products in more than 20 countries across the Middle East, Africa and Far East. Established in 1998, the company has developed into a major player in the MEA pharmaceutical market, earning a reputation for quality and reliability.

"At Globalpharma, we believe that the only way to succeed in the fast-changing health-care industry is to get ahead of the curve, and to drive change. We constantly strive for innovation and remain committed to emerge as a market leader in the MEA and beyond by manufacturing pharmaceutical products of the highest quality," Akhtar concluded.